
Katherine D. Salmon
Examiner (ID: 13858, Phone: (571)272-3316 , Office: P/1634 )
| Most Active Art Unit | 1634 |
| Art Unit(s) | 1682, 1634 |
| Total Applications | 1185 |
| Issued Applications | 352 |
| Pending Applications | 214 |
| Abandoned Applications | 645 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17357170
[patent_doc_number] => 20220017966
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-20
[patent_title] => METHODS AND COMPOSITIONS FOR CHARACTERIZING BLADDER CANCER
[patent_app_type] => utility
[patent_app_number] => 17/293775
[patent_app_country] => US
[patent_app_date] => 2019-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14414
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -37
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17293775
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/293775 | METHODS AND COMPOSITIONS FOR CHARACTERIZING BLADDER CANCER | Nov 14, 2019 | Pending |
Array
(
[id] => 17344027
[patent_doc_number] => 20220010358
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-13
[patent_title] => METHOD FOR DETECTION OF RNA
[patent_app_type] => utility
[patent_app_number] => 17/294364
[patent_app_country] => US
[patent_app_date] => 2019-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17279
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 156
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17294364
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/294364 | METHOD FOR DETECTION OF RNA | Nov 14, 2019 | Abandoned |
Array
(
[id] => 15867053
[patent_doc_number] => 20200140930
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-07
[patent_title] => DETECTION METHOD FOR NEISSERIA GONORRHOEAE
[patent_app_type] => utility
[patent_app_number] => 16/683897
[patent_app_country] => US
[patent_app_date] => 2019-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15815
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16683897
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/683897 | Detection method for Neisseria gonorrhoeae | Nov 13, 2019 | Issued |
Array
(
[id] => 16075609
[patent_doc_number] => 20200191791
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-18
[patent_title] => METHOD FOR DIAGNOSING LUNG CANCERS USING GENE EXPRESSION PROFILES IN PERIPHERAL BLOOD MONONUCLEAR CELLS
[patent_app_type] => utility
[patent_app_number] => 16/681046
[patent_app_country] => US
[patent_app_date] => 2019-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40270
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16681046
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/681046 | METHOD FOR DIAGNOSING LUNG CANCERS USING GENE EXPRESSION PROFILES IN PERIPHERAL BLOOD MONONUCLEAR CELLS | Nov 11, 2019 | Abandoned |
Array
(
[id] => 16253864
[patent_doc_number] => 20200263238
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-20
[patent_title] => DETECTION OF MYCOPLASMA IN CELL CULTURES AND CELL CULTURE DERIVED BIOLOGICALS
[patent_app_type] => utility
[patent_app_number] => 16/680460
[patent_app_country] => US
[patent_app_date] => 2019-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12329
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16680460
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/680460 | DETECTION OF MYCOPLASMA IN CELL CULTURES AND CELL CULTURE DERIVED BIOLOGICALS | Nov 10, 2019 | Abandoned |
Array
(
[id] => 17274827
[patent_doc_number] => 20210381025
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-09
[patent_title] => METHODS AND KITS FOR DETECTING CELLS USING OLIGONUCLEOTIDE CONJUGATED ANTIBODIES
[patent_app_type] => utility
[patent_app_number] => 17/285456
[patent_app_country] => US
[patent_app_date] => 2019-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35049
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -42
[patent_words_short_claim] => 178
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17285456
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/285456 | METHODS AND KITS FOR DETECTING CELLS USING OLIGONUCLEOTIDE CONJUGATED ANTIBODIES | Oct 30, 2019 | Abandoned |
Array
(
[id] => 17075150
[patent_doc_number] => 11111536
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-09-07
[patent_title] => Method for determining cross contamination of mouse genes for human cells in a patient-derived xenograft cells
[patent_app_type] => utility
[patent_app_number] => 16/666449
[patent_app_country] => US
[patent_app_date] => 2019-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 6724
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16666449
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/666449 | Method for determining cross contamination of mouse genes for human cells in a patient-derived xenograft cells | Oct 28, 2019 | Issued |
Array
(
[id] => 17274861
[patent_doc_number] => 20210381059
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-09
[patent_title] => USE OF LONG NON-CODING RNA FOR THE DIAGNOSIS OF PROSTATE CANCER
[patent_app_type] => utility
[patent_app_number] => 17/287132
[patent_app_country] => US
[patent_app_date] => 2019-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20840
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17287132
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/287132 | USE OF LONG NON-CODING RNA FOR THE DIAGNOSIS OF PROSTATE CANCER | Oct 23, 2019 | Pending |
Array
(
[id] => 16091367
[patent_doc_number] => 20200199670
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-25
[patent_title] => WHOLE-GENOME HAPLOTYPE RECONSTRUCTION
[patent_app_type] => utility
[patent_app_number] => 16/662352
[patent_app_country] => US
[patent_app_date] => 2019-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16547
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16662352
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/662352 | Whole-genome haplotype reconstruction | Oct 23, 2019 | Issued |
Array
(
[id] => 17292597
[patent_doc_number] => 20210388436
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-16
[patent_title] => PROBE HAVING OCTAMINE OR OCTAMINE DERIVATIVE BOUND THERETO, AND USES OF SAME
[patent_app_type] => utility
[patent_app_number] => 17/286483
[patent_app_country] => US
[patent_app_date] => 2019-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4511
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17286483
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/286483 | PROBE HAVING OCTAMINE OR OCTAMINE DERIVATIVE BOUND THERETO, AND USES OF SAME | Oct 20, 2019 | Abandoned |
Array
(
[id] => 17200507
[patent_doc_number] => 20210340602
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-04
[patent_title] => SINGLE-MOLECULE EPIGENETIC LOCALIZATION
[patent_app_type] => utility
[patent_app_number] => 17/283378
[patent_app_country] => US
[patent_app_date] => 2019-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8591
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17283378
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/283378 | SINGLE-MOLECULE EPIGENETIC LOCALIZATION | Oct 15, 2019 | Pending |
Array
(
[id] => 18093442
[patent_doc_number] => 20220411783
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-29
[patent_title] => METHOD FOR EXTRACTING NUCLEI OR WHOLE CELLS FROM FORMALIN-FIXED PARAFFIN-EMBEDDED TISSUES
[patent_app_type] => utility
[patent_app_number] => 17/284542
[patent_app_country] => US
[patent_app_date] => 2019-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 147365
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -72
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17284542
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/284542 | METHOD FOR EXTRACTING NUCLEI OR WHOLE CELLS FROM FORMALIN-FIXED PARAFFIN-EMBEDDED TISSUES | Oct 10, 2019 | Pending |
Array
(
[id] => 18036619
[patent_doc_number] => 20220380834
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-01
[patent_title] => METHODS AND COMPOSITIONS FOR HIGH SENSITIVITY DETECTION OF DRUG RESISTANCE MARKERS
[patent_app_type] => utility
[patent_app_number] => 17/282305
[patent_app_country] => US
[patent_app_date] => 2019-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 87980
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -145
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17282305
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/282305 | METHODS AND COMPOSITIONS FOR HIGH SENSITIVITY DETECTION OF DRUG RESISTANCE MARKERS | Oct 3, 2019 | Abandoned |
Array
(
[id] => 15346041
[patent_doc_number] => 20200010912
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-09
[patent_title] => PROGNOSTIC METHOD FOR INDIVIDUALS WITH PROSTATE CANCER
[patent_app_type] => utility
[patent_app_number] => 16/575940
[patent_app_country] => US
[patent_app_date] => 2019-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13125
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16575940
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/575940 | PROGNOSTIC METHOD FOR INDIVIDUALS WITH PROSTATE CANCER | Sep 18, 2019 | Abandoned |
Array
(
[id] => 17460681
[patent_doc_number] => 20220073986
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-10
[patent_title] => METHOD OF CHARACTERIZING A NEURODEGENERATIVE PATHOLOGY
[patent_app_type] => utility
[patent_app_number] => 17/276339
[patent_app_country] => US
[patent_app_date] => 2019-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29893
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -52
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17276339
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/276339 | METHOD OF CHARACTERIZING A NEURODEGENERATIVE PATHOLOGY | Sep 16, 2019 | Abandoned |
Array
(
[id] => 15290643
[patent_doc_number] => 20190388457
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-26
[patent_title] => PROGNOSTIC METHODS AND SYSTEMS OF TREATMENT FOR ACUTE LYMPHOBLASTIC LEUKEMIA
[patent_app_type] => utility
[patent_app_number] => 16/567233
[patent_app_country] => US
[patent_app_date] => 2019-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11431
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 148
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16567233
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/567233 | Prognostic methods and systems of treatment for acute lymphoblastic leukemia | Sep 10, 2019 | Issued |
Array
(
[id] => 17023478
[patent_doc_number] => 20210247349
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-12
[patent_title] => METHOD FOR PREPARING RATIOMETRIC ELECTROCHEMICAL miR3123 APTASENSOR BASED ON METAL-ORGANIC FRAMEWORK COMPOSITE
[patent_app_type] => utility
[patent_app_number] => 17/051781
[patent_app_country] => US
[patent_app_date] => 2019-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2776
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 657
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17051781
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/051781 | Method for preparing ratiometric electrochemical miR3123 aptasensor based on metal-organic framework composite | Aug 29, 2019 | Issued |
Array
(
[id] => 15621223
[patent_doc_number] => 20200081016
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-12
[patent_title] => BIOMARKERS FOR EARLY DIAGNOSIS AND DIFFERENTIATION OF MYCOBACTERIAL INFECTION
[patent_app_type] => utility
[patent_app_number] => 16/555819
[patent_app_country] => US
[patent_app_date] => 2019-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15692
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16555819
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/555819 | Biomarkers for early diagnosis and differentiation of mycobacterial infection | Aug 28, 2019 | Issued |
Array
(
[id] => 17170791
[patent_doc_number] => 20210324461
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-21
[patent_title] => REAGENTS, MIXTURES, KITS AND METHODS FOR AMPLIFICATION OF NUCLEIC ACIDS
[patent_app_type] => utility
[patent_app_number] => 17/250610
[patent_app_country] => US
[patent_app_date] => 2019-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35346
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -145
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17250610
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/250610 | REAGENTS, MIXTURES, KITS AND METHODS FOR AMPLIFICATION OF NUCLEIC ACIDS | Aug 15, 2019 | Pending |
Array
(
[id] => 17363724
[patent_doc_number] => 11230742
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-01-25
[patent_title] => Assays for fungal infection
[patent_app_type] => utility
[patent_app_number] => 16/542782
[patent_app_country] => US
[patent_app_date] => 2019-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 28
[patent_no_of_words] => 20678
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 198
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16542782
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/542782 | Assays for fungal infection | Aug 15, 2019 | Issued |